Corcept Therapeutics
CORT
CORT
208 hedge funds and large institutions have $1.59B invested in Corcept Therapeutics in 2021 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 61 increasing their positions, 87 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.03% more ownership
Funds ownership: 69.76% → 69.78% (+0.03%)
30% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 87
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
208
Holding in Top 10
1
Calls
$57M
Puts
$45.7M
Top Buyers
| 1 | +$63.6M | |
| 2 | +$15.1M | |
| 3 | +$5.17M | |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$5.04M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$4.93M |
Top Sellers
| 1 | -$21.2M | |
| 2 | -$19.8M | |
| 3 | -$14.2M | |
| 4 |
BlackRock
New York
|
-$10.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$6.82M |